Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Akela Pharma has received a contract at its PharmaForm subsidiary located in Austin, Texas, to process validate and manufacture Phase III registration batches for Proellex, a drug product developed by Repros Therapeutics.
Subscribe to our email newsletter
Michael Crowley, vice president of business development at PharmaForm, said: “We are very pleased to have been awarded this important contract and with our long relationship with Repros.
“Proellex will fill unmet medical needs and could be a blockbuster should it meet all clinical endpoints. It represents a great partnership and opportunity for both organizations.”